Figure 1 | Mouse CD8+NKT-like cells exert dual cytotoxicity against mouse tumor cells and myeloid-derived suppressor cells | SpringerLink
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors - ScienceDirect
Cancers | Free Full-Text | Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
In vitro education of human natural killer cells by KIR3DL1 | Life Science Alliance
Cells | Free Full-Text | Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stress
NK Textile - Home | Facebook
Combined CTL and NK cell cytotoxicity against cancer cells | bioRxiv
Frontiers | Memory and Memory-Like NK Cell Responses to Microbial Pathogens
NK cell development, homeostasis and function: parallels with CD8+ T cells | Nature Reviews Immunology
Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy | Journal for ImmunoTherapy of Cancer | Full Text
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications | Cellular & Molecular Immunology
Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity | PLOS ONE
Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity | EMBO Molecular Medicine
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways: Molecular Therapy - Methods & Clinical Development
Frontiers | CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Frontiers | NK Cell-Based Immune Checkpoint Inhibition
Generation of Natural Killer Cells from Human Pluripotent Stem Cells Using STEMdiff™ and StemSpan™ Media and Supplements
Human NK cells: From development to effector functions - Arosh Shavinda Perera Molligoda Arachchige, 2021
CAR-NK cells: A promising cellular immunotherapy for cancer - eBioMedicine